AUD 0.0
(-33.33%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 | 7130.00 AUD | -84.25% |
2023 | 45.27 Thousand AUD | -41.39% |
2022 | 77.23 Thousand AUD | 1116.94% |
2021 | 6347.00 AUD | -85.58% |
2020 | 44.02 Thousand AUD | 0.0% |
2019 | - AUD | 0.0% |
2018 | - AUD | 0.0% |
2017 | - AUD | 0.0% |
2016 | - AUD | 0.0% |
2015 | - AUD | 0.0% |
2014 | - AUD | 0.0% |
2013 | - AUD | 0.0% |
2012 | - AUD | 0.0% |
2011 | - AUD | 0.0% |
2010 | - AUD | 0.0% |
2009 | - AUD | 0.0% |
2008 | - AUD | 0.0% |
2007 | - AUD | 0.0% |
2006 | - AUD | 0.0% |
2005 | - AUD | 0.0% |
2004 | - AUD | 0.0% |
2003 | - AUD | 0.0% |
2002 | - AUD | 0.0% |
2001 | - AUD | 0.0% |
2000 | - AUD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 FY | 7130.00 AUD | -84.25% |
2024 Q2 | 28.04 Thousand AUD | 0.0% |
2024 Q4 | 7130.00 AUD | 0.0% |
2023 Q4 | 45.27 Thousand AUD | 0.0% |
2023 Q2 | 63.62 Thousand AUD | 0.0% |
2023 FY | 45.27 Thousand AUD | -41.39% |
2022 Q4 | 77.23 Thousand AUD | 0.0% |
2022 Q2 | 93.53 Thousand AUD | 0.0% |
2022 FY | 77.23 Thousand AUD | 1116.94% |
2021 FY | 6347.00 AUD | -85.58% |
2021 Q4 | 6347.00 AUD | 0.0% |
2021 Q2 | 25.85 Thousand AUD | 0.0% |
2020 Q4 | 44.02 Thousand AUD | 0.0% |
2020 FY | 44.02 Thousand AUD | 0.0% |
2020 Q2 | 60.82 Thousand AUD | 0.0% |
2019 Q2 | - AUD | 0.0% |
2019 Q4 | - AUD | 0.0% |
2019 FY | - AUD | 0.0% |
2018 Q2 | - AUD | 0.0% |
2018 FY | - AUD | 0.0% |
2018 Q4 | - AUD | 0.0% |
2017 Q4 | - AUD | 0.0% |
2017 FY | - AUD | 0.0% |
2017 Q2 | - AUD | 0.0% |
2016 Q4 | - AUD | 0.0% |
2016 FY | - AUD | 0.0% |
2016 Q2 | - AUD | 0.0% |
2015 FY | - AUD | 0.0% |
2015 Q4 | - AUD | 0.0% |
2015 Q2 | - AUD | 0.0% |
2014 Q2 | - AUD | 0.0% |
2014 FY | - AUD | 0.0% |
2014 Q4 | - AUD | 0.0% |
2013 Q3 | - AUD | 0.0% |
2013 Q2 | - AUD | 0.0% |
2013 FY | - AUD | 0.0% |
2013 Q1 | - AUD | 0.0% |
2013 Q4 | - AUD | 0.0% |
2012 Q4 | - AUD | 0.0% |
2012 FY | - AUD | 0.0% |
2011 FY | - AUD | 0.0% |
2011 Q4 | - AUD | 0.0% |
2010 FY | - AUD | 0.0% |
2010 Q4 | - AUD | 0.0% |
2009 Q4 | - AUD | 0.0% |
2009 FY | - AUD | 0.0% |
2008 Q4 | - AUD | 0.0% |
2008 FY | - AUD | 0.0% |
2007 Q4 | - AUD | 0.0% |
2007 FY | - AUD | 0.0% |
2006 FY | - AUD | 0.0% |
2006 Q4 | - AUD | 0.0% |
2005 FY | - AUD | 0.0% |
2005 Q4 | - AUD | 0.0% |
2004 Q4 | - AUD | 0.0% |
2004 FY | - AUD | 0.0% |
2003 FY | - AUD | 0.0% |
2003 Q4 | - AUD | 0.0% |
2002 FY | - AUD | 0.0% |
2002 Q4 | - AUD | 0.0% |
2001 FY | - AUD | 0.0% |
2001 Q4 | - AUD | 0.0% |
2000 FY | - AUD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
AdAlta Limited | 2.49 Million AUD | 99.714% |
Acrux Limited | 1.48 Million AUD | 99.521% |
Actinogen Medical Limited | 319.06 Thousand AUD | 97.765% |
AnteoTech Limited | 23.59 Thousand AUD | 69.778% |
Argenica Therapeutics Limited | - AUD | -Infinity% |
Arovella Therapeutics Limited | - AUD | -Infinity% |
Anatara Lifesciences Ltd | - AUD | -Infinity% |
Alterity Therapeutics Limited | 159.04 Thousand AUD | 95.517% |
Amplia Therapeutics Limited | 1.56 Million AUD | 99.543% |
Avecho Biotechnology Limited | 175.15 Thousand AUD | 95.929% |
Bio-Gene Technology Limited | - AUD | -Infinity% |
Biome Australia Limited | 1.3 Million AUD | 99.454% |
Botanix Pharmaceuticals Limited | - AUD | -Infinity% |
BTC Health Limited | - AUD | -Infinity% |
Chimeric Therapeutics Limited | - AUD | -Infinity% |
CSL Limited | 18.24 Billion AUD | 100.0% |
Clarity Pharmaceuticals Ltd | - AUD | -Infinity% |
Clinuvel Pharmaceuticals Limited | 879.78 Thousand AUD | 99.19% |
Cynata Therapeutics Limited | - AUD | -Infinity% |
Dimerix Limited | 149.68 Thousand AUD | 95.237% |
EZZ Life Science Holdings Limited | 123.85 Thousand AUD | 94.243% |
Hexima Limited | - AUD | -Infinity% |
Island Pharmaceuticals Limited | 421.96 Thousand AUD | 98.31% |
Immuron Limited | 173.49 Thousand AUD | 95.89% |
Immutep Limited | 1.22 Million AUD | 99.42% |
Imugene Limited | 1.54 Million AUD | 99.539% |
Invex Therapeutics Ltd | - AUD | -Infinity% |
Memphasys Limited | 4.41 Million AUD | 99.838% |
Nanollose Limited | 42.53 Thousand AUD | 83.235% |
Neuren Pharmaceuticals Limited | - AUD | -Infinity% |
Noxopharm Limited | - AUD | -Infinity% |
NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
Nyrada Inc. | - AUD | -Infinity% |
Orthocell Limited | 689.69 Thousand AUD | 98.966% |
PharmAust Limited | - AUD | -Infinity% |
Patrys Limited | - AUD | -Infinity% |
Paradigm Biopharmaceuticals Limited | 239.33 Thousand AUD | 97.021% |
Proteomics International Laboratories Limited | 316.39 Thousand AUD | 97.746% |
Prescient Therapeutics Limited | 330.48 Thousand AUD | 97.843% |
PYC Therapeutics Limited | 1.11 Million AUD | 99.359% |
Race Oncology Limited | - AUD | -Infinity% |
Radiopharm Theranostics Limited | - AUD | -Infinity% |
Recce Pharmaceuticals Ltd | 811.19 Thousand AUD | 99.121% |
Starpharma Holdings Limited | 3.52 Million AUD | 99.798% |
Telix Pharmaceuticals Limited | 17.44 Million AUD | 99.959% |
Tissue Repair Ltd | - AUD | -Infinity% |
Zelira Therapeutics Limited | 5.65 Million AUD | 99.874% |